Recipharm appoints new directors
May 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Henning Neubauer, Recipharm, lopez, wilander
Contract development and manufacturing organisation Recipharm has hired two new directors for its business management unit. Henning Neubauer (pictured) takes …
Euprotec hires new finance director
May 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing euprotec, hollinsworth
Manchester-based CRO firm Euprotec has appointed Mark Hollingworth as its finance director. Hollingworth spent a significant part of his career …
WHO: ‘Common infections will kill again’
May 1, 2014Research and Development, Sales and Marketing AMR, WHO, global, infection, world health organization
The world is heading for a situation where common infections which have long been thought to be no threat to …
Pfizer/AZ deal would put UK research in jeopardy
May 1, 2014Research and Development, Sales and Marketing AstraZeneca, Cameron, Pfizer, UK, deal, merger, research
The UK’s medical research collective has come together to warn the government that any deal between US giant Pfizer and …
Midatech makes two senior appointments
May 1, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing cook, midatech, stahel
UK-based nanomedicine firm Midatech has appointed Rolf Stahel as its chairman and Dr Craig Cook as chief operating and chief medical …
GSK sees profit fall
May 1, 2014Sales and Marketing Advair, China, GSK, Novartis, Q1, Seretide, Witty
GlaxoSmithKline has seen revenue and profit plummet in the first quarter of 2014. The UK-based company saw turnover fall 13% …
Pharma playing catch-up in mHealth race
April 30, 2014Medical Communications, Sales and Marketing GSK, Havas, butler, digital, gait, mhealth, mobile health, pm awards
Pharma risks falling behind in mobile health (mHealth) as more innovative industries capitalise on its emerging opportunities, according to two …
The doctor will Skype you now
April 30, 2014Medical Communications, Sales and Marketing CQC, NHS, Skype, babylon, digital, healthberry, parsa
A new smartphone app called Babylon is looking to give patients an ‘NHS in their pocket’ by allowing video consultations …
Merck’s Q1 sales drop
April 30, 2014Sales and Marketing AstraZeneca, Merck, Pfizer, Q1, merger, quarter, sales
Merck & Co has released a mixed set of results for the first quarter of 2014, with drug revenue falling …
FDA approves Zykadia for late-stage lung cancer
April 30, 2014Research and Development, Sales and Marketing Cancer, FDA, Novartis, lung, zykadia
Novartis’ ‘breakthrough’ drug Zykadia has been approved by the FDA to treat lung cancer patients with a particular genetic mutation. …
Lonza makes change at the top
April 30, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Lonza, funk
Swiss pharma supplier firm Lonza has confirmed a leadership change as its chief operating officer (COO) leaves. Marc Funk has …
Cancer Research funding to be doubled
April 30, 2014Research and Development, Sales and Marketing CRUK, Cancer, brain, breast, funding, lung
Cancer Research UK is to increase its research funding by 50% over the next decade as part of a new strategy …
Facebook dementia app created
April 29, 2014Medical Communications, Sales and Marketing Alzheimer's, Facebook, app, dementia
Alzheimer’s Research UK has launched a new Facebook app which allows users to see what it is like to suffer …
BMS expands Samsung deal
April 29, 2014Manufacturing and Production BMS, Roche, Samsung, UCSF, biologics, incheon
Bristol-Myers Squibb has expanded its biopharmaceutical manufacturing agreement with South Korea’s Samsung BioLogics. Last year, Bristol-Myers Squibb signed a 10-year …
‘Transformational’ NHS social media tool launches
April 29, 2014Medical Communications, Sales and Marketing NHS, digital, healthberry, king, social media
London-based startup firm HealthBerry has developed a social media web and mobile application that is set to transform how the …
Pfizer ‘significantly undervalued’ AstraZeneca
April 29, 2014Sales and Marketing AstraZeneca, Pfizer, acquisition, buyout, merger
AstraZeneca has broken its silence to insist that Pfizer’s financial offer in January for the company “very significantly undervalued AstraZeneca …
PrimeVigilance appoints chief medical officer
April 29, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing primevigilance, seebeck
Pharmacovigilance and medical services firm PrimeVigilance has appointed Dr Joerg Seebeck as its chief medical officer. Seebeck is to head …
Humira drives AbbVie again
April 28, 2014Sales and Marketing AbbVie, Abbott, Humira, RA
Rheumatoid arthritis treatment Humira has once more driven AbbVie, bringing in more than half the company’s sales in the first …
NICE chair: pharma must show how it prices drugs
April 28, 2014Research and Development, Sales and Marketing Goldacre, Haslam, NICE, VBP, all trials, pars
The pharmaceutical industry must be willing to show the public how it prices its drugs – or face losing its …
Latest content
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
